[Three new cases of Duhring-Brocq disease having benefited from combined aureomycin-nivaquine therapy].
D002738:Chloroquine; D002751:Chlortetracycline / Q000627:therapeutic use*; D003874:Dermatitis Herpetiformis / Q000628:therapy*; D011616:Psychotherapy, Multiple; D011804:Quinolines / Q000627:therapeutic use*; D014528:Uricosuric Agents
D011804:Quinolines; D014528:Uricosuric Agents; D002738:Chloroquine; D002751:Chlortetracycline
CHLORTETRACYCLINE/therapeutic use; DERMATITIS HERPETIFORMIS/therapy; QUINOLINES/therapeutic use
Trois nouveaux cas de maladie de Duhring-Brocq ayant bénéficié d'un traitement par l'association auréomycine-nivaquine.